|Mutations in FLT3 as a therapeutic target|
A research published this week in the journal Nature, validates certain activating mutations in the FLT3 gene as targets for acute myeloid leukemia therapy -- a critically important finding for developing drugs. An italian researcher, Sara Salerno, working at the Division of Hematology/Oncology, University of California, took part to the research.
To read the article click here
Make a donation
Support ISSNAF programs and operations.
Donations to ISSNAF are tax deductible.
Find out who works in your area of expertise or geographic area. ISSNAF Database Search engine allows you to easily view and export contact selections.
Long and short term mentorships aimed at supporting under-40 ISSNAF affiliates in their career choices and professional growth.
Send us your texts, videos or podcasts to: firstname.lastname@example.org
Register in the ISSNAF Roster of Reviewers of the Italian Ministry of Health Bando Ricerca Finalizzata 2011/12